Other Affiliated Sites
开元体育(中国)官方网站
开元体育·(中国)官方APP下载
开元体育平台(中国)官方网站app下载
开元体育官网(中国)官方下载-IOS/安卓通用版/手机APP下载
开云app(中国)官方网站-ios/安卓版/手机版app下载
开云·APP官方入口(中国)官方网站-IOS/安卓通用版/手机app
开云·APP(kaiyun)(中国)官方网站-IOS/Android通用版/手机app下载
华体会·(HTH)官网APP下载 - Apple app store
江南体育·(中国)官方网站 - ios/安卓版/手机APP下载
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Preparations Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
2021.07.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2021.06.29
2020年年度权益分派实施公告
2021.06.28
开元体育官网app手机版下载公司债券2020年定期受托管理事务报告
2021.06.28
开元体育官网app手机版下载2016年公司债券受托管理事务年度报告（2020年度）
2021.06.24
H股公告
2021.06.23
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE III CLINICAL TRIAL OF ...
2021.06.11
H股公告
2021.06.10
VOLUNTARY ANNOUNCEMENT “INHIXA” OBTAINS APPROVAL FROM BOSNIA AND HERZEGOVINA
2021.06.10
关于第二期和第三期员工持股计划的提示性公告
2021.06.10
VOLUNTARY ANNOUNCEMENT - "INHIXA" OBTAINS APPROVAL FROM BOSNIA AND HERZEGOVINA
第一页
上一页
14
15
16
17
18
下一页
最后一页
